These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

534 related items for PubMed ID: 23702489

  • 1. [Single center experience of (18F)-fluorocholine positron emission tomography: analysis of its impact on salvage local therapy in patients with prostate adenocarcinoma].
    Moussaid Y, Bonardel G, Jacob J, Métivier D, Gontier E, Bauduceau O, Durand X, Fayolle M, Houlgatte A, Foehrenbach H, Védrine L, Chargari C.
    Cancer Radiother; 2013; 17(4):259-64. PubMed ID: 23702489
    [Abstract] [Full Text] [Related]

  • 2. [PET/CT with (11)C-choline and (18)F-FDG in patients with elevated PSA after radical treatment of a prostate cancer].
    García JR, Soler M, Blanch MA, Ramírez I, Riera E, Lozano P, Pérez X, Delgado E, Carrio I, Lomeña F.
    Rev Esp Med Nucl; 2009; 28(3):95-100. PubMed ID: 19558948
    [Abstract] [Full Text] [Related]

  • 3. ¹⁸F-choline positron emission tomography/computed tomography-driven high-dose salvage radiation therapy in patients with biochemical progression after radical prostatectomy: feasibility study in 60 patients.
    D'Angelillo RM, Sciuto R, Ramella S, Papalia R, Jereczek-Fossa BA, Trodella LE, Fiore M, Gallucci M, Maini CL, Trodella L.
    Int J Radiat Oncol Biol Phys; 2014 Oct 01; 90(2):296-302. PubMed ID: 25084612
    [Abstract] [Full Text] [Related]

  • 4. Clinical utility of (18)F-fluorocholine positron-emission tomography/computed tomography (PET/CT) in biochemical relapse of prostate cancer after radical treatment: results of a multicentre study.
    Rodado-Marina S, Coronado-Poggio M, García-Vicente AM, García-Garzón JR, Alonso-Farto JC, de la Jara AC, Maldonado-Suárez A, Rodríguez-Fernández A.
    BJU Int; 2015 Jun 01; 115(6):874-83. PubMed ID: 25307619
    [Abstract] [Full Text] [Related]

  • 5. Value of 18F-Choline PET/MRI hybrid technique on the therapeutic approach for patients with prostate cancer treated with prostatectomy and rising prostate specific antigen levels below 1 ng/ml.
    García JR, Compte A, Buxeda M, Mourelo S, Soler M, Blanch A, Valls E, Riera E.
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020 Jun 01; 39(4):197-203. PubMed ID: 32165153
    [Abstract] [Full Text] [Related]

  • 6. Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?
    Goldstein J, Even-Sapir E, Ben-Haim S, Saad A, Spieler B, Davidson T, Berger R, Weiss I, Appel S, Lawrence YR, Symon Z.
    Am J Clin Oncol; 2017 Jun 01; 40(3):256-259. PubMed ID: 25319322
    [Abstract] [Full Text] [Related]

  • 7. 18F-choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/mL) after radical prostatectomy.
    Vees H, Buchegger F, Albrecht S, Khan H, Husarik D, Zaidi H, Soloviev D, Hany TF, Miralbell R.
    BJU Int; 2007 Jun 01; 99(6):1415-20. PubMed ID: 17428249
    [Abstract] [Full Text] [Related]

  • 8. [Biochemical recurrence after curative treatment for localized prostate cancer: Performance of choline PET/CT in the assessment of local recurrence].
    Poncet D, Arnoux V, Descotes JL, Rambeaud JJ, Verry C, Terrier N, Boillot B, Dubreuil J, Lanchon C, Carnicelli D, Fiard G, Long JA.
    Prog Urol; 2015 May 01; 25(6):325-30. PubMed ID: 25748788
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Positron emission tomography/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: meaningful at PSA < 5 ng/ml?
    Heinisch M, Dirisamer A, Loidl W, Stoiber F, Gruy B, Haim S, Langsteger W.
    Mol Imaging Biol; 2006 May 01; 8(1):43-8. PubMed ID: 16315004
    [Abstract] [Full Text] [Related]

  • 14. [PET/CT and biochemical recurrence of prostate adenocarcinoma: Added value of 68Ga-PSMA-11 when 18F-fluorocholine is non-contributive].
    Gauthé M, Belissant O, Girard A, Zhang Yin J, Ohnona J, Cottereau AS, Nataf V, Balogova S, Pontvert D, Lebret T, Guillonneau B, Cussenot O, Talbot JN.
    Prog Urol; 2017 May 01; 27(8-9):474-481. PubMed ID: 28576423
    [Abstract] [Full Text] [Related]

  • 15. Early biochemical relapse after radical prostatectomy: which prostate cancer patients may benefit from a restaging 11C-Choline PET/CT scan before salvage radiation therapy?
    Castellucci P, Ceci F, Graziani T, Schiavina R, Brunocilla E, Mazzarotto R, Pettinato C, Celli M, Lodi F, Fanti S.
    J Nucl Med; 2014 Sep 01; 55(9):1424-9. PubMed ID: 24935990
    [Abstract] [Full Text] [Related]

  • 16. Influence of (11)C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancer.
    Souvatzoglou M, Krause BJ, Pürschel A, Thamm R, Schuster T, Buck AK, Zimmermann F, Molls M, Schwaiger M, Geinitz H.
    Radiother Oncol; 2011 May 01; 99(2):193-200. PubMed ID: 21620494
    [Abstract] [Full Text] [Related]

  • 17. Localizing sites of disease in patients with rising serum prostate-specific antigen up to 1ng/ml following prostatectomy: How much information can conventional imaging provide?
    Vargas HA, Martin-Malburet AG, Takeda T, Corradi RB, Eastham J, Wibmer A, Sala E, Zelefsky MJ, Weber WA, Hricak H.
    Urol Oncol; 2016 Nov 01; 34(11):482.e5-482.e10. PubMed ID: 27346339
    [Abstract] [Full Text] [Related]

  • 18. Usefulness of 18F-Choline Positron Emission Tomography - Computed Tomography in the therapeutic management of patients with biochemical recurrence of prostate adenocarcinoma treated with brachytherapy.
    López Rodríguez E, Tirado Hospital JL, Álvarez Pérez RM, Gómez Izquierdo L, Jiménez-Hoyuela JM.
    Actas Urol Esp (Engl Ed); 2020 Nov 01; 44(6):437-443. PubMed ID: 32576406
    [Abstract] [Full Text] [Related]

  • 19. Target definition in salvage postoperative radiotherapy for prostate cancer: 18F-fluorocholine PET/CT assessment of local recurrence.
    El Kabbaj O, Robin P, Bourhis D, Dissaux G, Rosenfelder N, Valeri A, Fournier G, Salaun PY, Pradier O, Malhaire JP, Abgral R, Schick U.
    Acta Oncol; 2018 Mar 01; 57(3):375-381. PubMed ID: 28984165
    [Abstract] [Full Text] [Related]

  • 20. 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse.
    Oyama N, Miller TR, Dehdashti F, Siegel BA, Fischer KC, Michalski JM, Kibel AS, Andriole GL, Picus J, Welch MJ.
    J Nucl Med; 2003 Apr 01; 44(4):549-55. PubMed ID: 12679398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.